A small clinical trial with a pharmacokinetic sub-study, led by a world-renowned pharmacologist at the University of Houston, has demonstrated the promising effectiveness of the drug Riluzole for improving functionality in people with acute spinal cord injuries (SCI) if the drug is taken within 12 hours post-injury.
FDA grants approval for updated mRNA vaccines for Covid-19
The vaccines aim to offer better protection against hospitalisation and death due to the virus. Credit: pedro7merino/Shutterstock. The US Food and Drug Administration (FDA) has
August 23, 2024